UQCRHP4

Across TCGA pan-cancer cohorts, UQCRHP4 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated UQCRHP4 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher UQCRHP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UQCRHP4 expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

LIHC, READ, and UVM are the cancer types where UQCRHP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.203	0.453	<.001	84	view →
READ	DFS	Tertile	IV	0.183	0.639	.002	27	view →
UVM	DFS	Quartile	All	0.293	0.674	.008	19	view →
UCEC	OS	Tertile	All	0.904	0.928	.036	18	view →
THCA	OS	Tertile	All	0.240	0.931	.018	18	view →
LGG	OS	Tertile	All	0.207	0.532	.011	12	view →
OV	OS	Tertile	III,IV	0.890	0.811	.029	12	view →
GBM	DFS	Tertile	All	0.096	0.249	.010	9	view →
DLBC	OS	Tertile	All	0.200	0.906	.012	6	view →
KIRP	OS	Tertile	All	0.213	0.714	.028	6	view →
SKCM	OS	Tertile	III,IV	0.503	0.340	.031	6	view →
SARC	OS	Tertile	All	0.312	0.628	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

UQCRHP4–LIHC (DFS)

Open the LIHC breakdown →